Merit Medical Systems, Inc. (MMSI) financial statements (2022 and earlier)

Company profile

Business Address 1600 WEST MERIT PARK WAY
SOUTH JORDAN, UT 84095
State of Incorp. UT
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments68697059574550
Cash and cash equivalents68697059574550
Restricted cash and investments2      
Receivables170161162159154150147
Inventory, net of allowances, customer advances and progress billings222208195200198209221
Inventory222208195200198209221
Prepaid expense4444443
Other undisclosed current assets17212017172724
Total current assets:482463450438430435446
Noncurrent Assets
Operating lease, right-of-use asset66687175787779
Property, plant and equipment372373374378383384384
Long-term investments and receivables 151414 1517
Long-term investments 151212 1215
Accounts and financing receivable, after allowance for credit loss  22 33
Intangible assets, net (including goodwill)362362363363364354353
Goodwill362362363363364354353
Deferred income tax assets6555544
Other noncurrent assets41413837383536
Other undisclosed noncurrent assets319316329342368368397
Total noncurrent assets:1,1661,1801,1931,2131,2351,2361,270
TOTAL ASSETS:1,6481,6431,6421,6521,6641,6711,716
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities217195191188165166154
Accounts payable56515453504744
Accrued liabilities159142135132112117107
Taxes payable3233322
Debt88888820
Other undisclosed current liabilities111112121313 
Total current liabilities:236213211208185186174
Noncurrent Liabilities
Long-term debt and lease obligation296335351381415419475
Long-term debt, excluding current maturities234271285313344350403
Operating lease, liability62646668716972
Liabilities, other than long-term debt76828986106131138
Accounts payable and accrued liabilities0000000
Deferred revenue2222222
Deferred compensation liability, classified18171716171514
Deferred income tax liabilities32333333334545
Liability for uncertainty in income taxes1111122
Other liabilities24283534536674
Total noncurrent liabilities:372416439467521551613
Total liabilities:608630650675706737787
Stockholders' equity
Stockholders' equity attributable to parent1,0401,013992977959934929
Common stock642634624615606601596
Accumulated other comprehensive loss(8)(6)(5)(7)(5)(9)(12)
Retained earnings406386374369358342345
Total stockholders' equity:1,0401,013992977959934929
TOTAL LIABILITIES AND EQUITY:1,6481,6431,6421,6521,6641,6711,716

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues278267280249258244218
Cost of revenue
(Cost of Goods and Services Sold)
(150)(147)(156)(137)(147)(142)(134)
Gross profit:12912012411211110284
Operating expenses(107)(105)(115)(98)(95)(102)(103)
Operating income (loss):2216914160(19)
Nonoperating expense(2)(2)(2)(2)(3)(2)(3)
Investment income, nonoperating0000000
Other nonoperating expense(1)(1)(1)(0)(1)(0)(1)
Interest and debt expense(1)(1)(1)(2)(2)(2)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes   2223
Income (loss) from continuing operations before equity method investments, income taxes:191351313(2)(22)
Other undisclosed income from continuing operations before income taxes111    
Income (loss) from continuing operations before income taxes:201471313(2)(22)
Income tax expense (benefit)0(2)(2)(2)2(1)3
Net income (loss) available to common stockholders, diluted:211251115(3)(19)

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):211251115(3)(19)
Other comprehensive income (loss)(2)(1)2(2)432
Comprehensive income (loss), net of tax, attributable to parent:19117919(0)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: